496 related articles for article (PubMed ID: 33148439)
1. Cognitive disorders associated with hospitalization of COVID-19: Results from an observational cohort study.
Zhou J; Liu C; Sun Y; Huang W; Ye K
Brain Behav Immun; 2021 Jan; 91():383-392. PubMed ID: 33148439
[TBL] [Abstract][Full Text] [Related]
2. The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline.
Pyne JD; Brickman AM
Neurodegener Dis; 2021; 21(1-2):1-23. PubMed ID: 34348321
[TBL] [Abstract][Full Text] [Related]
3. Measuring the cognitive costs of the COVID-19 pandemic.
Day GS
Mol Neurodegener; 2021 Sep; 16(1):67. PubMed ID: 34556131
[No Abstract] [Full Text] [Related]
4. The 'third wave': impending cognitive and functional decline in COVID-19 survivors.
Baker HA; Safavynia SA; Evered LA
Br J Anaesth; 2021 Jan; 126(1):44-47. PubMed ID: 33187638
[No Abstract] [Full Text] [Related]
5. Cognitive impact of COVID-19: looking beyond the short term.
Miners S; Kehoe PG; Love S
Alzheimers Res Ther; 2020 Dec; 12(1):170. PubMed ID: 33380345
[TBL] [Abstract][Full Text] [Related]
6. Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia.
Alonso-Lana S; Marquié M; Ruiz A; Boada M
Front Aging Neurosci; 2020; 12():588872. PubMed ID: 33192483
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Respiratory and Neurological Sequelae of COVID-19.
Wang F; Kream RM; Stefano GB
Med Sci Monit; 2020 Nov; 26():e928996. PubMed ID: 33177481
[TBL] [Abstract][Full Text] [Related]
8. The Impact of COVID-19 Infection and Enforced Prolonged Social Isolation on Neuropsychiatric Symptoms in Older Adults With and Without Dementia: A Review.
Manca R; De Marco M; Venneri A
Front Psychiatry; 2020; 11():585540. PubMed ID: 33192732
[No Abstract] [Full Text] [Related]
9. Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants.
Ho FK; Petermann-Rocha F; Gray SR; Jani BD; Katikireddi SV; Niedzwiedz CL; Foster H; Hastie CE; Mackay DF; Gill JMR; O'Donnell C; Welsh P; Mair F; Sattar N; Celis-Morales CA; Pell JP
PLoS One; 2020; 15(11):e0241824. PubMed ID: 33152008
[TBL] [Abstract][Full Text] [Related]
10. Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases?
Verkhratsky A; Li Q; Melino S; Melino G; Shi Y
Biol Direct; 2020 Nov; 15(1):28. PubMed ID: 33246479
[TBL] [Abstract][Full Text] [Related]
11. Direct and indirect neurological, cognitive, and behavioral effects of COVID-19 on the healthy elderly, mild-cognitive-impairment, and Alzheimer's disease populations.
Iodice F; Cassano V; Rossini PM
Neurol Sci; 2021 Feb; 42(2):455-465. PubMed ID: 33409824
[TBL] [Abstract][Full Text] [Related]
12. The impact of COVID-19 pandemic on people with mild cognitive impairment/dementia and on their caregivers.
Tsapanou A; Papatriantafyllou JD; Yiannopoulou K; Sali D; Kalligerou F; Ntanasi E; Zoi P; Margioti E; Kamtsadeli V; Hatzopoulou M; Koustimpi M; Zagka A; Papageorgiou SG; Sakka P
Int J Geriatr Psychiatry; 2021 Apr; 36(4):583-587. PubMed ID: 33166418
[TBL] [Abstract][Full Text] [Related]
13. Delirium Assessment in Critically Ill Older Adults: Considerations During the COVID-19 Pandemic.
Duggan MC; Van J; Ely EW
Crit Care Clin; 2021 Jan; 37(1):175-190. PubMed ID: 33190768
[TBL] [Abstract][Full Text] [Related]
14. Cognitive testing in the COVID-19 era: can existing screeners be adapted for telephone use?
Larner AJ
Neurodegener Dis Manag; 2021 Feb; 11(1):77-82. PubMed ID: 33172353
[No Abstract] [Full Text] [Related]
15. Frequent neurocognitive deficits after recovery from mild COVID-19.
Woo MS; Malsy J; Pöttgen J; Seddiq Zai S; Ufer F; Hadjilaou A; Schmiedel S; Addo MM; Gerloff C; Heesen C; Schulze Zur Wiesch J; Friese MA
Brain Commun; 2020; 2(2):fcaa205. PubMed ID: 33376990
[TBL] [Abstract][Full Text] [Related]
16. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA.
Taquet M; Luciano S; Geddes JR; Harrison PJ
Lancet Psychiatry; 2021 Feb; 8(2):130-140. PubMed ID: 33181098
[TBL] [Abstract][Full Text] [Related]
17. Neurocognitive deficits in severe COVID-19 infection: Case series and proposed model.
Whiteside DM; Oleynick V; Holker E; Waldron EJ; Porter J; Kasprzak M
Clin Neuropsychol; 2021 May; 35(4):799-818. PubMed ID: 33487098
[No Abstract] [Full Text] [Related]
18. Does COVID-19 contribute to development of neurological disease?
Mahalakshmi AM; Ray B; Tuladhar S; Bhat A; Paneyala S; Patteswari D; Sakharkar MK; Hamdan H; Ojcius DM; Bolla SR; Essa MM; Chidambaram SB; Qoronfleh MW
Immun Inflamm Dis; 2021 Mar; 9(1):48-58. PubMed ID: 33332737
[TBL] [Abstract][Full Text] [Related]
19. Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK Biobank.
Petermann-Rocha F; Hanlon P; Gray SR; Welsh P; Gill JMR; Foster H; Katikireddi SV; Lyall D; Mackay DF; O'Donnell CA; Sattar N; Nicholl BI; Pell JP; Jani BD; Ho FK; Mair FS; Celis-Morales C
BMC Med; 2020 Nov; 18(1):355. PubMed ID: 33167965
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of delirium, depression, anxiety, and post-traumatic stress disorder among COVID-19 patients: protocol for a living systematic review.
Shi J; Gao Y; Zhao L; Li Y; Yan M; Niu MM; Chen Y; Song Z; Zhang R; Zhang L; Tian J
Syst Rev; 2020 Nov; 9(1):258. PubMed ID: 33158456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
